LOINC codes

109,325 codes · page 32 of 2,187 · by category · by group · panels

LOINCNameClass
101393-7 CLCN7 gene full mutation analysis or Tissue (Blood, molecular genetics method) MOLPATH
101394-5 Sex in Embryo (molecular genetics method) MOLPATH
101395-2 Translocation analysis in Embryo (molecular genetics method) MOLPATH.TRNLOC
101396-0 Preimplantation multigene analysis in Embryo (molecular genetics method) MOLPATH
101397-8 Copy number variation analysis or Tissue (Blood, sequencing) MOLPATH
101398-6 Monkeypox virus and Orthopoxvirus.non-variola DNA panel - Specimen PANEL.MICRO
101399-4 Monkeypox virus and Orthopoxvirus.non-variola DNA in Specimen (naa with probe detection) MICRO
1014-0 E sup(w) Ag on Red Blood Cells from Donor (qualitative) BLDBK
10140-2 T' wave amplitude in lead V5 EKG.MEAS
101400-0 Metanephrine, Normetanephrine, 3-Methoxytyramine panel - 24 hour Urine PANEL.DRUG/TOX
101401-8 Tapentadol and Nortapentadol panel - Urine PANEL.DRUG/TOX
101402-6 Phenylalanine and Tyrosine panel - Serum or Plasma PANEL.CHEM
101403-4 Borrelia burgdorferi.VlsE1+pepC10 IgG+IgM Ab (qualitative, immunoassay) MICRO
101404-2 Borrelia afzelii+burgdorferi+garinii Ab.IgG and IgM panel - Serum or Plasma (immunoassay) PANEL.MICRO
101405-9 Amyloid protein Document (Tissue) CHEM
101406-7 Sudan virus RNA (Blood, qualitative, naa with probe detection) MICRO
101407-5 Laceyella sacchari IgG Ab MICRO
101408-3 Sesamum indicum 1 IgE Ab RAST class (qualitative) ALLERGY
101409-1 Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel - Serum PANEL.MICRO
10141-0 T' wave amplitude in lead V6 EKG.MEAS
101410-9 C peptide post XXX challenge panel - Serum PANEL.CHAL
101411-7 Dupilumab (lc/ms/ms --trough) DRUG/TOX
101412-5 Dolutegravir (lc/ms/ms --trough) DRUG/TOX
101413-3 Bictegravir (lc/ms/ms --trough) DRUG/TOX
101414-1 Lymphocyte TCR alpha beta double negative subsets panel - Blood PANEL.CELLMARK
101415-8 Blastomyces sp and Blastomyces dermatitidis Ag panel PANEL.MICRO
101416-6 Pediatric autoimmune central nervous system disorders evaluation panel - Cerebral spinal fluid PANEL.CHEM
101417-4 Pediatric autoimmune central nervous system disorders evaluation panel - Serum or Plasma PANEL.CHEM
101418-2 Microorganism level similarity to reference sample in Isolate or Specimen (ms.maldi-tof) MICRO
101419-0 Human coronavirus 229E RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
10142-8 T wave amplitude in lead AVF EKG.MEAS
101420-8 Human coronavirus HKU1 RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101421-6 Human coronavirus NL63 RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101422-4 Human coronavirus OC43 RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101423-2 Influenza virus A H1 RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101424-0 Influenza virus A H3 RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101425-7 Respiratory syncytial virus A RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101426-5 Respiratory syncytial virus B RNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101427-3 Shigella sp DNA (Stool, qualitative, naa with probe detection) MICRO
101428-1 Varicella zoster virus DNA in Respiratory system specimen (qualitative, naa with probe detection) MICRO
101429-9 MDS v3.0 - RAI v1.18.11 - Self-care - discharge performance during assessment period PANEL.SURVEY.CMS
10143-6 T wave amplitude in lead AVL EKG.MEAS
101430-7 MDS v3.0 - RAI v1.18.11 - Self-Care - OBRA/Interim Performance PANEL.SURVEY.CMS
101431-5 MDS v3.0 - RAI v1.18.11 - Mobility - discharge performance PANEL.SURVEY.CMS
101432-3 MDS v3.0 - RAI v1.18.11 - Mobility - OBRA/Interim Performance PANEL.SURVEY.CMS
101433-1 Bacterial vaginosis score in Vaginal fluid Qualitative (qualitative, nugent) MICRO
101434-9 2-Ketobutyrate CHEM
101435-6 MDS v3.0 - RAI v1.18.11 - Referral PANEL.SURVEY.CMS
101436-4 MDS v3.0 - RAI v1.18.11 - Discharge plan PANEL.SURVEY.CMS
101437-2 FDA product label Intentional animal genomic alteration label DOCUMENT.REGULATORY